Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru
HIV Infections, Hiv, Sexually Transmitted Infections (Not HIV or Hepatitis)
About this trial
This is an interventional prevention trial for HIV Infections focused on measuring prevention, relationship functioning, adherence, prevention strategies
Eligibility Criteria
Inclusion Criteria: being assigned male at birth and currently identifying as male (cis-gender); having had anal sex with each other in the past 3 months; referring to each other as being in a relationship, defined as "someone you feel emotionally or romantically committed to above all others, and may be referred to as partner, husband, partner, etc."; being in a relationship with each other for 3 months or longer; being at least 18 years of age; not having any history of intimate partner violence since their relationship began; self-reporting not feeling coerced by their partner to take part in the study activities; having their own Internet/web-connected device (e.g. smartphone, laptop, tablet, computer); living in the Lima metro area and planning to live there for the next 6 months; willing to receive an in-person rapid HIV test (if applicable); willing to be tested for other STIs and use swabs to self-collect their own specimens; and willing to attend an in-person appointment at baseline and at 6 months. Exclusion Criteria: -Does not meet one or more of the inclusion criteria
Sites / Locations
- Florida International UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Intervention
Waitlist Control
From baseline to 6 months, participants randomized to the intervention arm will have access to the P3 web app intervention and all of its contents (5 modules, resources, etc.), including post-baseline assessments that will occur at 3 months and 6 months.
From baseline to 3-months, participants in the waitlist control condition will have access to the P3 web app for post-baseline assessment of 3 months and the resources section. From 3 months to 6 months, participants randomized to the waitlist control arm will then have access to the P3 web app intervention and all of its contents (5 modules, resources, etc.), including post-baseline assessment that will occur at 6 months.